Methodological considerations on immunoadsorption versus sham treatment for post-COVID syndrome
Kamyar Mansori, Mojtaba Soltani-Kermanshahi · 2026
Read Methodological considerations on immunoadsorption versus sham treatment for post-COVID syndrome by Kamyar Mansori, Mojtaba Soltani-Kermanshahi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571250.txt.
Description
Kamyar Mansori and Mojtaba Soltani-Kermanshahi raise points in a 2026 letter on a trial of blood filtering for post-COVID illness. The trial swapped patients between true filtering, which pulls out self-attacking proteins, and a sham run, to see if symptom load fell. The letter team asks if the swap plan was guarded well enough.
A swap trial can blur results when the first care keeps acting in the next phase, they note. A rest gap can prevent that blur, but the study did not set one out. They also saw no test for such carry-over effects, though old guides urge one at the start. No checks that the data fit a bell curve were shown either. These gaps, they say, should temper how the results are read.
Catalog record
| CREATOR | Kamyar Mansori, Mojtaba Soltani-Kermanshahi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |